Results 261 to 270 of about 57,330 (350)

Fixed Drug Eruption due to Dupilumab. [PDF]

open access: yesActa Derm Venereol
Kaneoka A   +3 more
europepmc   +1 more source

Allopurinol‐Induced Lymphadenopathy: A Case Report

open access: yes
ACR Open Rheumatology, Volume 7, Issue 12, December 2025.
Mikako Harata, Aparna Das
wiley   +1 more source

Treatment of Pyoderma Gangrenosum With Bimekizumab

open access: yesJEADV Clinical Practice, Volume 4, Issue 5, Page 1174-1177, December 2025.
ABSTRACT Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis with no FDA‐approved treatments. Current therapies, including corticosteroids and immunomodulators, often show limited efficacy and nonspecific, conferring to higher risk of adverse events.
Kareena S. Garg   +2 more
wiley   +1 more source

Chlorzoxazone-Induced Fixed Drug Eruption: A Clinical Case Report. [PDF]

open access: yesInt Med Case Rep J
Alotaibi H   +4 more
europepmc   +1 more source

Superficial Pustular Folliculitis of the Face and Neck—A Non‐Infectious Eruption Responding to Topical Steroids

open access: yesJEADV Clinical Practice, Volume 4, Issue 5, Page 1057-1067, December 2025.
Twenty‐seven young patients, mostly females, presenting with monomorphous, discrete, tiny, superficial follicular pustules on the face (44.4%), the face and neck (51.8%) and the neck (3.7%). The eruption was itchy in 44.4%, recurrent in 81% of cases and responded well to topical corticosteroids. Histopathologic findings of 3 cases revealed infundibular
Hui‐Peng Huang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy